NCT03567720 2023-06-01
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
OncoSec Medical Incorporated
Phase 2 Unknown
OncoSec Medical Incorporated
Ludwig-Maximilians - University of Munich
GERCOR - Multidisciplinary Oncology Cooperative Group